Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Affimed N.V. (AFMD)

Affimed N.V. (AFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,792
  • Shares Outstanding, K 16,100
  • Annual Sales, $ 8,960 K
  • Annual Income, $ -114,660 K
  • EBIT $ -76 M
  • EBITDA $ -74 M
  • 60-Month Beta 2.10
  • Price/Sales 5.39
  • Price/Cash Flow N/A
  • Price/Book 2.55

Options Overview Details

View History
  • Implied Volatility 156.22% ( +1.82%)
  • Historical Volatility 70.06%
  • IV Percentile 62%
  • IV Rank 14.10%
  • IV High 1,075.58% on 02/05/24
  • IV Low 5.31% on 02/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 80
  • Volume Avg (30-Day) 38
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 1,076
  • Open Int (30-Day) 871

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.53
  • Number of Estimates 4
  • High Estimate -0.16
  • Low Estimate -0.94
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.65 +1.51%
on 11/21/24
4.04 -33.44%
on 11/14/24
-0.71 (-20.89%)
since 10/21/24
3-Month
2.65 +1.51%
on 11/21/24
4.51 -40.29%
on 08/29/24
-1.57 (-36.86%)
since 08/21/24
52-Week
2.65 +1.51%
on 11/21/24
8.95 -69.95%
on 06/12/24
-2.18 (-44.77%)
since 11/21/23

Most Recent Stories

More News
Affimed N.V. Completes Enrollment in NSCLC Cohort and Prepares for Data Presentations at ASH 2024

Affimed N.V. reports on clinical trials, financial results, and updates on cash position through Q4 2025.Quiver AI SummaryAffimed N.V. announced the completion of enrollment in the EGFR wild-type non-small...

AFMD : 2.67 (-1.84%)
Affimed N.V.: Q3 Earnings Snapshot

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 2.67 (-1.84%)
Affimed N.V.: Q2 Earnings Snapshot

Affimed N.V.: Q2 Earnings Snapshot

AFMD : 2.67 (-1.84%)
Affimed N.V.: Q1 Earnings Snapshot

Affimed N.V.: Q1 Earnings Snapshot

AFMD : 2.67 (-1.84%)
Affimed N.V.: Q3 Earnings Snapshot

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 2.67 (-1.84%)
Affimed N.V.: Q2 Earnings Snapshot

Affimed N.V.: Q2 Earnings Snapshot

AFMD : 2.67 (-1.84%)
Affimed N.V.: Q1 Earnings Snapshot

Affimed N.V.: Q1 Earnings Snapshot

AFMD : 2.67 (-1.84%)
Why Shares of Affimed Fell Thursday

The clinical-stage biotech focuses on immuno-oncology therapies.

AFMD : 2.67 (-1.84%)
Affimed N.V.: Q3 Earnings Snapshot

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 2.67 (-1.84%)
Why Affimed Stock Plummeted by Over 16% Today

An analyst's downgrade brings out the bears for the European cancer treatment developer.

AFMD : 2.67 (-1.84%)
SF : 115.25 (+1.60%)

Business Summary

Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V.,...

See More

Key Turning Points

3rd Resistance Point 3.24
2nd Resistance Point 3.13
1st Resistance Point 2.93
Last Price 2.67
1st Support Level 2.62
2nd Support Level 2.51
3rd Support Level 2.31

See More

52-Week High 8.95
Fibonacci 61.8% 6.54
Fibonacci 50% 5.80
Fibonacci 38.2% 5.06
Last Price 2.67
52-Week Low 2.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar